Chad M. Robins, CEO and Chairman at Adaptive Biotechnologies Corp (ADPT), sold 470,167 shares at $13.17 ($6.2M) on 2026-03-11, disclosed to the SEC on 2026-03-13.
Seasonal sale ($6.2M) by CEO and Chairman — this insider has traded ADPT in March in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $13.17 | 140,567 | $1.9M | 29.9% |
| 2 | $13.17 | 329,600 | $4.3M | 70.1% |
| Total | $13.17 avg | 470,167 | $6.2M | 100% |
| Filing → |
| ADPT | SELL | 2026-03-03 | $8.3M | — | Filing → |
| ADPT | SELL | 2026-02-04 | $2.3M | — | Filing → |
| ADPT | SELL | 2026-01-07 | $1.9M | — | Filing → |